Schond Greenway
Chief Financial Officer at KaliVir Immunotherapeutics
New York, New York, United States
Find your path to Schond
436 people in our graph share verified history with Schond — schools, employers, funds. One of them is your warm intro.
Adrianna MaunlockedSchond: together at Morgan Stanley (2000)
×10Schond: together at Morgan Stanley
Schond: together at Bank of America
Chief Financial Officer at KaliVir Immunotherapeutics
Intro paths
→
In turn, Schond can intro founders to KaliVir Immunotherapeutics's investors below.
KaliVir Immunotherapeutics's investors · 1
Co-founders at KaliVir Immunotherapeutics
ST
Stephen ThorneCo-founder & Chief Scientific Officer
Experience
- KaliVir ImmunotherapeuticsChief Financial Officercurrent2024 — presentGreater New York City / Greater Pittsburgh
- MindMedChief Financial Officer2022 — 2024Greater New York City
- Avalo TherapeuticsChief Financial Officer2021 — 2022Greater Philadelphia
- Mesoblast LimitedVice President (Global Head), Investor Relations2016 — 2021Greater New York City Area
- Halozyme Therapeutics, Inc.Executive Director, Strategy & Investor Relations2013 — 2016San Diego County, California, United States
- Cantor Fitzgerald affiliateManaging Director, Head Desk Analyst2011 — 2013New York City Metropolitan Area
- Barclays CapitalVice President2007 — 2011New York City Metropolitan Area
- DURECT CorporationVice President, Head of IR and Strategic Planning2000 — 2007San Francisco Bay Area
- Morgan StanleySenior Associate - Investment Banking (Institutional Securities Division)1994 — 2000New York City Metropolitan Area
- Bank of AmericaAssociate - Investment Banking1997Charlotte, North Carolina
Skills & more
Initial Public Offerings (IPO)Information TechnologyStrategic PartnershipsCrisis ManagementPublic RelationsSEC Financial ReportingP&L ManagementSalesEquities10Mergers & Acquisitions11Valuation12Private Equity7
+8 more
Investment BankingCorporate FinanceInvestmentsCorporate DevelopmentFinancial ModelingCapital MarketsInvestor RelationsAlternative InvestmentsFrom Schond's professional profile.
Frequently asked questions
- Who is Schond Greenway?
- Chief Financial Officer at KaliVir Immunotherapeutics
- Where does Schond Greenway work?
- Schond Greenway is Chief Financial Officer at KaliVir Immunotherapeutics.
- Where did Schond Greenway go to school?
- Schond Greenway studied at University of Virginia Darden School of Business (Master of Business Administration (MBA), General Management); Florida Agricultural and Mechanical University (Bachelor of Science (B.S.), Computer/Information Technology Administration and Management).
Same school
Also attended University of Virginia Darden School of Business237
Cathy FriedmanInvestor at GV (Google Ventures)Dan LynchInvestor at GV (Google Ventures)Rajan MehraPartner at March Capital PartnersRob LudwigChief Operating Officer at Hoxton VenturesMatt BolanderBusiness Operations Associate at QED InvestorsJennifer SchretterGeneral Partner - Secondaries at PROOF
+ 231 more
Also attended Florida Agricultural and Mechanical University30
Floyd H. GriffithManaging Partner at Little Bristol PartnersRondall AllenBoard Member at Maryland TEDCOShila Nieves BurneyManaging Partner at Zane Venture FundLivi GrantInvestor at MaC Venture CapitalMeaghan GamboaAssociate, Investments at Acumen AmericaSydney HolnessInvestment Associate at Collab Capital
+ 24 more
Shared employers
Also worked at MindMed2
Also worked at Avalo Therapeutics16
Aaron KantoffManaging Partner at Scion Life SciencesSamantha TruexInvestor at Avalo TherapeuticsChris SullivanChief Financial Officer at Avalo TherapeuticsMittie DoyleChief Medical Officer at Avalo TherapeuticsPaul VarkiChief Legal Officer at Avalo TherapeuticsJennifer RileyChief Strategy Officer at Avalo Therapeutics
+ 10 more
Also worked at Barclays Capital333
Bertie AykroydPartner at Mayfair Equity PartnersShemina MekkyExecutive Assistant, MENA at Golden Gate VenturesSunil RaoCOO, SVP Finance at Plum Alley InvestmentsJarrid TingleInvestor at Harlem Capital PartnersPhil VenablesVenture Partner at Ballistic VenturesAngela AsencioManager, Therapeutics Team at Deerfield Management Company
+ 327 more
